December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Stephanie Graff: First 3rd-generation HER2-directed ADC in neoadjuvant HER2+ Breast Cancer
Dec 14, 2024, 16:05

Stephanie Graff: First 3rd-generation HER2-directed ADC in neoadjuvant HER2+ Breast Cancer

Stephanie Graff, Director of Breast Oncology at Brown University Health and an Associate Professor of Medicine at Brown University’s Legorreta Cancer Center, shared a post on X:

“First 3rd-generation HER2-directed ADC in neoadjuvant HER2+ BC.

SHR-A1811 monotherapy is efficacious (PCR 63.2% and well tolerated.,

Is there a future where we can build on an ADC instead of the current standard of care 4 drug combo?”

Stephanie Graff: First 3rd-generation HER2-directed ADC in neoadjuvant HER2+ Breast Cancer

Stephanie Graff is the Director of Breast Oncology at Brown University Health and an Associate Professor of Medicine at Brown University’s Legorreta Cancer Center. She also serves as the Director of Breast Oncology at Lifespan and is a Medical Advisor for the Dr. Susan Love Foundation for Breast Cancer Research.She is an Associate Editor of Cancer Medicine, and chairs the editorial board of Oncology Times.